Fibronostics Achieves SOC 2 Compliance
Fibronostics is now officially SOC 2 Type II compliant! This compliance reflects our deep commitment to keeping your data and […]
Fibronostics is now officially SOC 2 Type II compliant! This compliance reflects our deep commitment to keeping your data and […]
When it comes to liver disease, early intervention isn’t just helpful, it’s critical. Known as the body’s “silent organ,” the
Inflammatory Bowel Disease (IBD), which includes Crohn’s disease and ulcerative colitis, is primarily known for affecting the gastrointestinal tract. However,
High blood pressure doesn’t just strain your heart – it may quietly damage your liver too. Several studies, including a
We did it again! Fibronostics is proud to announce that we have successfully renewed our ISO 27001:2022 certification for
Liver disease often progresses silently, with early stages showing minimal or no symptoms. However, the encouraging news is that these
Liver steatosis commonly known as fatty liver is no longer a silent bystander in liver health. It’s the central feature
When people think about liver disease, the conversation usually centers around fibrosis – the amount of permanent scarring in the